Orally efficacious lead of the AVG inhibitor series targeting a dynamic interface in the respiratory syncytial virus polymerase.
Sci Adv
; 8(25): eabo2236, 2022 06 24.
Article
in En
| MEDLINE
| ID: mdl-35749502
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Respiratory Tract Infections
/
Respiratory Syncytial Virus, Human
/
Respiratory Syncytial Virus Infections
Limits:
Animals
/
Humans
Language:
En
Journal:
Sci Adv
Year:
2022
Type:
Article
Affiliation country:
United States